Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Finished Goods (2018 - 2026)

TransMedics has reported Finished Goods over the past 8 years, most recently at $20.6 million for Q4 2025.

  • For Q4 2025, Finished Goods rose 35.23% year-over-year to $20.6 million; the TTM value through Dec 2025 reached $20.6 million, up 35.23%, while the annual FY2025 figure was $20.6 million, 35.23% up from the prior year.
  • Finished Goods for Q4 2025 was $20.6 million at TransMedics, down from $22.6 million in the prior quarter.
  • Over five years, Finished Goods peaked at $22.6 million in Q3 2025 and troughed at $4.1 million in Q1 2021.
  • A 5-year average of $12.3 million and a median of $13.6 million in 2023 define the central range for Finished Goods.
  • Biggest five-year swings in Finished Goods: surged 135.44% in 2023 and later fell 20.85% in 2025.
  • Year by year, Finished Goods stood at $5.7 million in 2021, then surged by 37.8% to $7.8 million in 2022, then surged by 87.5% to $14.6 million in 2023, then rose by 4.43% to $15.3 million in 2024, then surged by 35.23% to $20.6 million in 2025.
  • Business Quant data shows Finished Goods for TMDX at $20.6 million in Q4 2025, $22.6 million in Q3 2025, and $15.8 million in Q2 2025.